Table 3 Study variables associated with the prevalence of total hip joint replacements
THR (n = 435) | p value | THR | p value | |
|---|---|---|---|---|
Multivariate 1 | Multivariate 2 | |||
Age (per year) | 1.02 (1.00–1.04) | 0.02 | 1.03 (1.01–1.04) | 0.01 |
Female sex | 1.42 (1.15–1.76) | 0.001 | 1.52 (1.20–1.92) | <0.0001 |
BMI (per unit) | 1.04 (1.01–1.06) | 0.002 | 1.04 (1.01–1.06) | 0.003 |
Finger length ratio (1–3) | 1.05 (0.91–1.24) | 0.52 | 1.05 (0.91–1.22) | 0.49 |
Hand OA severity (0–4) | 1.15 (1.07–1.24) | <0.0001 | 1.15 (1.07–1.24) | <0.0001 |
BMD (per 10 percent of predicted) | 1.05 (1.02–1.08) | 0.002 | 1.05 (1.02–1.08) | 0.003 |
Education (1–4) | 1.13 (1.01–1.26) | 0.04 | ||
Smoking history (1–3) | 1.04 (0.89–1.21) | 0.67 | ||
hs-CRP | 1.00 (0.99–1.02) | 0.69 | ||
Cholesterol | 0.99 (0.89–1.11) | 0.89 | ||
Triglycerides | 0.98 (0.83–1.45) | 0.82 | ||
Statin use | 1.10 (0.83–1.45) | 0.53 | ||
AUC (95 % CI): | 0.61 (0.59–0.64) | 0.62 (0.59–0.64) | ||
R 2 : Cragg-Uhler (Nagelkerke): | 0.03 | 0.03 |